Project Number 1R42NS129400-01 Agency/Funding Organization NINDS Funding Year 2022 View Full Project Details for Commercialization of Selective Dyrk1a Inhibitors for Down Syndrome Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) t. Other Researcher and Organization Principal Investigator DUNCKLEY, TRAVIS Principal Investigator First Name TRAVIS Principal Investigator Last Name DUNCKLEY Awardee Organization ILUMINOS THERAPEUTICS, LLC Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PA-21-262: PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) FY Overall Cost $498,634 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official GILCHRIST, FLOY ANNETTE
